Company profile DXR

Daxor Corp.
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 20:48:53.

After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0.
Daxor Corporation expected interest is significantly higher compared to previous quarter (+1009.5%) and same quarter last year (+323.6%).

YearQ1Q2Q3Q4
201910
70
600.0% QoQ
42
-40.0% QoQ
45
7.1% QoQ
2020 26
160.0% YoY -42.2% QoQ
32
-54.3% YoY 23.1% QoQ
0
-100.0% YoY -100.0% QoQ
19
-57.8% YoY inf% QoQ
2021 0
-100.0% YoY -100.0% QoQ
43
34.4% YoY inf% QoQ
91
inf% YoY 111.6% QoQ
24
26.3% YoY -73.6% QoQ
2022 24
inf% YoY 0.0% QoQ
51
18.6% YoY 112.5% QoQ
7
-92.3% YoY -86.3% QoQ
26
8.3% YoY 271.4% QoQ
2023 55
129.2% YoY 111.5% QoQ
61
19.6% YoY 10.9% QoQ
28
300.0% YoY -54.1% QoQ
21
-19.2% YoY -25.0% QoQ
2024 100
81.8% YoY 376.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Daxor Corporation search interest

There is not enough data for Daxor Corporation to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:48:54.

The average 5 years interest of Daxor Corporation was 2.97 per week.
The last year interest of Daxor Corporation compared to the last 5 years has changed by 48.82%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 28.49%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BVA-100 Blood Volume Analyzer to provide analysis

Correlation between past revenue and BVA-100 Blood Volume Analyzer search interest

There is not enough data for BVA-100 Blood Volume Analyzer to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BVA-100 Blood Volume Analyzer to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Blood volume measurement technology to provide analysis

Correlation between past revenue and Blood volume measurement technology search interest

There is not enough data for Blood volume measurement technology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Blood volume measurement technology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Daxor Corporation stock to provide analysis

Correlation between past revenue and Daxor Corporation stock search interest

There is not enough data for Daxor Corporation stock to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Daxor Corporation stock to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Daxor Corporation news to provide analysis

Correlation between past revenue and Daxor Corporation news search interest

There is not enough data for Daxor Corporation news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Daxor Corporation news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Daxor Corporation medical devices to provide analysis

Correlation between past revenue and Daxor Corporation medical devices search interest

There is not enough data for Daxor Corporation medical devices to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Daxor Corporation medical devices to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Safe blood volume test to provide analysis

Correlation between past revenue and Safe blood volume test search interest

There is not enough data for Safe blood volume test to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Safe blood volume test to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Objective blood volume test to provide analysis

Correlation between past revenue and Objective blood volume test search interest

There is not enough data for Objective blood volume test to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Objective blood volume test to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Daxor Corporation competitors to provide analysis

Correlation between past revenue and Daxor Corporation competitors search interest

There is not enough data for Daxor Corporation competitors to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Daxor Corporation competitors to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Daxor Corporation careers to provide analysis

Correlation between past revenue and Daxor Corporation careers search interest

There is not enough data for Daxor Corporation careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Daxor Corporation careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for DXR
Earnings date: 2024-02-29
Company name: Daxor Corp.
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-28T12:00:00Z

GlobeNewswire
Daxor Leverages MedAxiom CV Transforum Spring'26 to Accelerate Commercial Adoption of Blood Volume Analysis

2026-04-08T12:00:00Z

GlobeNewswire
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center

2026-03-26T12:00:00Z

GlobeNewswire
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026

2026-03-10T12:00:00Z

GlobeNewswire
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress

2026-03-09T12:00:00Z

GlobeNewswire
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026

2026-03-03T13:30:00Z

GlobeNewswire
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

2026-03-03T13:00:00Z

GlobeNewswire
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share

2026-02-24T13:00:00Z

GlobeNewswire
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee

2026-02-10T13:00:00Z

GlobeNewswire
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business

2026-01-23T13:00:00Z

GlobeNewswire
Daxor Corporation Announces $9 Million Registered Direct Offering

2025-11-25T13:00:00Z

GlobeNewswire
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer

2025-10-21T12:00:00Z

GlobeNewswire
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit

2025-10-15T16:25:42-04:00

SEC
N-CSR/A Form - [Amend] Certified Shareholder Report - DAXOR CORP (0000027367) (Filer)

2025-10-15T12:00:00Z

GlobeNewswire
Daxor's New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25

2025-10-02T15:13:38-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - DAXOR CORP (0000027367) (Issuer)